Cardiovascular Outcomes in Sleep-Disordered Breathing: Are We Under-estimating?

Overview

Journal Front Neurol

Specialty Neurology

Date 2022 Apr 4

PMID 35370882

Authors

Muhammad Yasir

Amina Pervaiz

Abdulghani Sankari

Affiliations

Soon will be listed here.

Abstract

Obstructive sleep apnea is a growing health concern, affecting nearly one billion people worldwide; increasingly recognized as an independent cardiovascular risk factor associated with incident obesity, insulin resistance, hypertension, arrhythmias, stroke, coronary artery disease, and heart failure. The prevalence of obstructive sleep apnea could be underestimated in the previous studies, leading to only modest predictions of cardiovascular outcomes. Using more physiologic data will increase sensitivity for the diagnosis of obstructive sleep apnea. Individuals at high risk of obstructive sleep apnea should be identified so that treatment efforts can be focused on them. This review will assess the evidence for the relationship between obstructive sleep apnea and cardiovascular consequences in the past, present, and future. We will also explore the role of adding physiological data obtained from sleep studies and its ability to enhance the cardiovascular outcome's predictability. Finally, we will discuss future directions and gaps that need further research.

Citing Articles

Sleep Apnea and Heart Failure-Current State-of-The-Art.

Menon T, Kalra D Int J Mol Sci. 2024; 25(10).

PMID: 38791288 PMC: 11121476. DOI: 10.3390/ijms25105251.

Prevalences of sleep-related breathing disorders and severity factors in chronic spinal cord injury and abled-bodied individuals undergoing rehabilitation: a comparative study.

Souza Bastos P, Amaral T, Yehia H, Tavares A J Clin Sleep Med. 2024; 20(7):1119-1129.

PMID: 38420961 PMC: 11217642. DOI: 10.5664/jcsm.11084.

Unveiling the sleep-cardiovascular connection: Novel perspectives and interventions-A narrative review.

Berjaoui C, Kibrom B, Ghayyad M, Joumaa S, Talal Al Labban N, Nazir A Health Sci Rep. 2023; 6(12):e1773.

PMID: 38107151 PMC: 10723785. DOI: 10.1002/hsr2.1773.

Management of obesity across women's life course: FIGO Best Practice Advice.

Maxwell C, Shirley R, OHiggins A, Rosser M, OBrien P, Hod M Int J Gynaecol Obstet. 2023; 160 Suppl 1:35-49.

PMID: 36635081 PMC: 10107516. DOI: 10.1002/ijgo.14549.

Cardiovascular Complications of Obstructive Sleep Apnea in the Intensive Care Unit and Beyond.

Wahab A, Chowdhury A, Jain N, Surani S, Mushtaq H, Khedr A Medicina (Kaunas). 2022; 58(10).

PMID: 36295551 PMC: 9609939. DOI: 10.3390/medicina58101390.

References

Oldenburg O, Wellmann B, Buchholz A, Bitter T, Fox H, Thiem U . Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients. Eur Heart J. 2015; 37(21):1695-703. DOI: 10.1093/eurheartj/ehv624. View

Ballester E, Badia J, Hernandez L, Carrasco E, de Pablo J, Fornas C . Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999; 159(2):495-501. DOI: 10.1164/ajrccm.159.2.9804061. View

Sankari A, Pranathiageswaran S, Maresh S, Hosni A, Badr M . Characteristics and Consequences of Non-apneic Respiratory Events During Sleep. Sleep. 2017; 40(1). PMC: 6410940. DOI: 10.1093/sleep/zsw024. View

Shahrbabaki S, Linz D, Hartmann S, Redline S, Baumert M . Sleep arousal burden is associated with long-term all-cause and cardiovascular mortality in 8001 community-dwelling older men and women. Eur Heart J. 2021; 42(21):2088-2099. PMC: 8197565. DOI: 10.1093/eurheartj/ehab151. View

Santamaria-Martos F, Benitez I, Ortega F, Zapater A, Giron C, Pinilla L . Circulating microRNA profile as a potential biomarker for obstructive sleep apnea diagnosis. Sci Rep. 2019; 9(1):13456. PMC: 6748919. DOI: 10.1038/s41598-019-49940-1. View

Li K, Chen Z, Qin Y, Wei Y . MiR-664a-3p expression in patients with obstructive sleep apnea: A potential marker of atherosclerosis. Medicine (Baltimore). 2018; 97(6):e9813. PMC: 5944670. DOI: 10.1097/MD.0000000000009813. View

Mazzotti D, Keenan B, Lim D, Gottlieb D, Kim J, Pack A . Symptom Subtypes of Obstructive Sleep Apnea Predict Incidence of Cardiovascular Outcomes. Am J Respir Crit Care Med. 2019; 200(4):493-506. PMC: 6701040. DOI: 10.1164/rccm.201808-1509OC. View

Zhao G . Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases. J Med Genet. 2018; 55(11):713-720. PMC: 6252363. DOI: 10.1136/jmedgenet-2018-105387. View

Redline S, Yenokyan G, Gottlieb D, Shahar E, OConnor G, Resnick H . Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med. 2010; 182(2):269-77. PMC: 2913239. DOI: 10.1164/rccm.200911-1746OC. View

10.

Loube D, Gay P, Strohl K, Pack A, White D, Collop N . Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest. 1999; 115(3):863-6. DOI: 10.1378/chest.115.3.863. View

11.

Cadby G, McArdle N, Briffa T, Hillman D, Simpson L, Knuiman M . Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort. Chest. 2015; 148(4):945-952. DOI: 10.1378/chest.15-0229. View

12.

Malhotra A, Ayappa I, Ayas N, Collop N, Kirsch D, McArdle N . Metrics of sleep apnea severity: beyond the apnea-hypopnea index. Sleep. 2021; 44(7). PMC: 8271129. DOI: 10.1093/sleep/zsab030. View

13.

Sankari A, Ravelo L, Maresh S, Aljundi N, Alsabri B, Fawaz S . Longitudinal effect of nocturnal R-R intervals changes on cardiovascular outcome in a community-based cohort. BMJ Open. 2019; 9(7):e030559. PMC: 6661586. DOI: 10.1136/bmjopen-2019-030559. View

14.

Marin J, Carrizo S, Vicente E, Agusti A . Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365(9464):1046-53. DOI: 10.1016/S0140-6736(05)71141-7. View

15.

Jenkinson C, Davies R, Mullins R, Stradling J . Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet. 1999; 353(9170):2100-5. DOI: 10.1016/S0140-6736(98)10532-9. View

16.

Bixler E, Vgontzas A, Lin H, ten HAVE T, Rein J, Vela-Bueno A . Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med. 2001; 163(3 Pt 1):608-13. DOI: 10.1164/ajrccm.163.3.9911064. View

17.

Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S . The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993; 328(17):1230-5. DOI: 10.1056/NEJM199304293281704. View

18.

Young T, Palta M, Dempsey J, Peppard P, Nieto F, Hla K . Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ. 2009; 108(5):246-9. PMC: 2858234. View

19.

Khalyfa A, Zhang C, Khalyfa A, Foster G, Beaudin A, Andrade J . Effect on Intermittent Hypoxia on Plasma Exosomal Micro RNA Signature and Endothelial Function in Healthy Adults. Sleep. 2016; 39(12):2077-2090. PMC: 5103796. DOI: 10.5665/sleep.6302. View

20.

Li K, Wei P, Qin Y, Wei Y . MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in obstructive sleep apnea patients. Medicine (Baltimore). 2017; 96(34):e7917. PMC: 5572039. DOI: 10.1097/MD.0000000000007917. View